SS Innovations International Inc. Common Stock (SSII) is a publicly traded Healthcare sector company. As of October 13, 2026, SSII trades at $2.54 with a market cap of $529.00M and a P/E ratio of -46.72. SSII moved -0.39% today. Year to date, SSII is -55.11%; over the trailing twelve months it is -63.31%. Its 52-week range spans $2.50 to $22.42. Rallies surfaces SSII's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SS Innovations submits response to FDA information request on SSi Mantra 510(k) filing: SS Innovations submitted its response to an FDA request for additional information on its 510(k) filing for the SSi Mantra. FDA review is expected to conclude in Q1 2027 for an initial cholecystectomy indication.
| Metric | Value |
|---|---|
| Price | $2.54 |
| Market Cap | $529.00M |
| P/E Ratio | -46.72 |
| EPS | $-0.06 |
| Dividend Yield | 0.00% |
| 52-Week High | $22.42 |
| 52-Week Low | $2.50 |
| Volume | 250 |
| Avg Volume | 0 |
| Revenue (TTM) | $42.48M |
| Net Income | $-12.13M |
| Gross Margin | 46.00% |
SSII analyst coverage data. Average price target: $0.00.